Population-based cohort validation and replication reveals limited generalizability of cluster-based MASLD subtypes
Related Experiment Video
Updated: Jan 13, 2026
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Aims:
MASLD, defined as a steatotic liver disease in the presence of one or more cardiometabolic risk factors and the absence of harmful alcohol intake, exhibits substantial heterogeneity complicating risk stratification. A prior clustering model proposed liver-specific and cardiometabolic subtypes, yet its generalizability and prognostic relevance remain unclear in the broader population. We aim to validate and replicate the prior approach in a nationally representative U.S.
Materials And Methods:
We included 3300 participants with MASLD from NHANES III. For validation, participants were assigned to previously defined clusters using published medoids. For replication, de novo clusters were derived using the Partitioning Around Medoids algorithm. Cox proportional hazards models accounting for the complex survey design of NHANES III were used to estimate hazard ratios for all-cause, cardiovascular-related, and diabetes-related mortality across clusters.
Results:
Individual cluster assignments showed limited reproducibility between the validation and replication analyses, although the overall clustering pattern was preserved. Based on clinical profiles, clusters were categorized into cardiometabolic, liver-specific, and other subtypes. The cardiometabolic cluster consistently showed higher risks in both analyses, while the liver-specific cluster showed no significant associations.
Conclusions:
The subtyping model demonstrated limited generalizability. Nonetheless, the consistent identification of broad cardiometabolic and liver-specific patterns suggests potential value for risk stratification, pending further validation.
Insights
A new study on metabolic dysfunction-associated steatotic liver disease (MASLD) found that while a prior subtyping model had limited generalizability, cardiometabolic and liver-specific patterns consistently emerged for risk stratification.
Area of Science:
- Cardiology
- Hepatology
- Epidemiology
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) presents significant heterogeneity, complicating risk stratification.
- Previous clustering models identified liver-specific and cardiometabolic subtypes but lacked validation in broader populations.
Purpose of the Study:
- To validate and replicate a prior clustering model for MASLD subtypes.
- To assess the prognostic relevance of these subtypes for mortality risks.
Main Methods:
- Utilized data from 3300 MASLD participants in the National Health and Nutrition Examination Survey (NHANES III).
- Employed Partitioning Around Medoids for cluster derivation and Cox proportional hazards models for mortality risk analysis.
- Validated and replicated subtype assignments to assess generalizability.
Main Results:
- Cluster assignments showed limited reproducibility between validation and replication, but overall patterns persisted.
- Identified broad cardiometabolic and liver-specific subtypes.
- The cardiometabolic cluster was associated with consistently higher mortality risks, while the liver-specific cluster showed no significant associations.
Conclusions:
- The MASLD subtyping model demonstrated limited generalizability.
- Consistent identification of cardiometabolic and liver-specific patterns suggests potential utility for risk stratification, requiring further validation.
